SynCore Biotechnology Co (ROCO:4192) Net Issuance of Preferred Stock : NT$0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

SynCore Biotechnology Co's net issuance of preferred for the three months ended in Mar. 2025 was NT$0.00 Mil. The number is 0, which means that SynCore Biotechnology Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

SynCore Biotechnology Co's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.00 Mil.

SynCore Biotechnology Co Net Issuance of Preferred Stock Historical Data

The historical data trend for SynCore Biotechnology Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Net Issuance of Preferred Stock Chart

SynCore Biotechnology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

SynCore Biotechnology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

SynCore Biotechnology Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

SynCore Biotechnology Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

SynCore Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269

Website

https://www.syncorebio.com

SynCore Biotechnology Co Ltd is a Biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.

SynCore Biotechnology Co Headlines

No Headlines